Ameisen, Jean Claude
Université Paris Cité,
France
2025 Rank: 56215
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1629 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56215 | 58458 |
| Total Cites | 6621 | 7385 |
| H-index | 40 | 42 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 1060 | 1102 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1537 | 1636 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 4271 | 4660 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5766 | 6107 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
10.35%
|
|
Ameisen, Jean Claude
Inserm,
France
2024 Rank: 52926
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1566 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52926 | 54736 |
| Total Cites | 6492 | 7246 |
| H-index | 40 | 42 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 1016 | 1058 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1490 | 1588 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 4191 | 4575 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5653 | 5991 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
10.41%
|
|
Ameisen, Jean Claude
Inserm,
France
2023 Rank: 49273
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1491 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49273 | 50846 |
| Total Cites | 6380 | 7124 |
| H-index | 40 | 42 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 985 | 1027 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1456 | 1554 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 4131 | 4512 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5551 | 5883 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
10.44%
|
|
Ameisen, Jean Claude
Inserm,
France
2022 Rank: 46267
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1443 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46267 | 48068 |
| Total Cites | 6237 | 6966 |
| H-index | 40 | 42 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 949 | 991 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1415 | 1513 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 4044 | 4416 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5416 | 5741 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
10.47%
|
|
Ameisen, Jean Claude
Inserm,
France
2021 Rank: 44400
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1388 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44400 | 45866 |
| Total Cites | 6119 | 6812 |
| H-index | 40 | 42 |
| Hm-index | 13 | 15 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 918 | 960 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1380 | 1475 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 3962 | 4318 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5305 | 5620 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
10.17%
|
|
Ameisen, Jean Claude
Inserm,
France
2020 Rank: 40123
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1284 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40123 | 40861 |
| Total Cites | 5975 | 6656 |
| H-index | 39 | 42 |
| Hm-index | 13 | 15 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 892 | 934 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1348 | 1443 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 3890 | 4239 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5165 | 5474 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.22 |
| Self-Citation Percentage |
10.23%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.